C. Difficile Toxin Gene Amplification Assay
Main Filters
C. Difficile Toxin Gene Amplification Assay
| BECTON, DICKINSON AND COMPANY | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 441916 | 0 | - | ||
| 443418 | 0 | - | ||
| DIAGNOSTIC HYBRIDS, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| M307 | 0 | - | ||
| DIASORIN MOLECULAR LLC | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| MOL2950 | 0 | - | ||
| MOL2960 | 0 | - | ||
| MOL5290 | 0 | - | ||
| GenePoc Inc | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 132994 | 0 | - | ||
| GREAT BASIN SCIENTIFIC, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| GBCDIFF-10 | 0 | - | ||
| LUMINEX CORPORATION | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 20-006-022 | 0 | - | ||
| 20-009-022 | 0 | - | ||
| 20-011-022 | 0 | - | ||
| 30-002-022 | 0 | - | ||
| 50-10018 | 0 | - | ||
| Meridian Bioscience Canada Inc | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 410300 | 0 | - | ||
| MERIDIAN BIOSCIENCE, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 401300 | 0 | - | ||
| NANOSPHERE, INC. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 20-006-022 | 0 | - | ||
| 20-009-022 | 0 | - | ||
| 20-011-022 | 0 | - | ||
| 30-002-022 | 0 | - | ||
| QIAGEN GmbH | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 4572346 | 0 | - | ||
| QUIDEL CORPORATION | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| M105 | 0 | - | ||
| M201 | 0 | - | ||
| Vela Operations USA Inc. | ||||
| CATALOG # | QTY | PRICE | DESCRIPTION | |
| 300786 | 0 | - | ||
| CDF2-SPD | 0 | - | ||
24 Results
Results Per Page
- 50
- 100
- 250
Catalog #
AvailableQty
Starting At
Name
Company Name
Description
0
-
Portrait Toxigenic C. difficile Assay
GREAT BASIN SCIENTIFIC, INC.
C. diff Assay Cartridge and Sample Prep Device.
0
-
Clostridium difficile (CDF) Stool Sample Preparation Kit
NANOSPHERE, INC.
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
0
-
Clostridium difficile (CDF) Amplification Tray
NANOSPHERE, INC.
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
0
-
Clostridium difficile (CDF) Extraction Tray
NANOSPHERE, INC.
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
0
-
Clostridium difficile (CDF) Nucleic Acid Test Cartridge
NANOSPHERE, INC.
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
0
-
Revogene C. difficile
MERIDIAN BIOSCIENCE, INC.
The Revogene C. difficile assay performed on the Revogene instrument is a qualitative in vitro diagnostic test that utilizes automated sample processing and real time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection. The Revogene C. difficile assay is intended to aid in the diagnosis of CDI.
0
-
Clostridium difficile (CDF) Stool Sample Preparation Kit
LUMINEX CORPORATION
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
0
-
Clostridium difficile (CDF) Amplification Tray
LUMINEX CORPORATION
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
0
-
Clostridium difficile (CDF) Extraction Tray
LUMINEX CORPORATION
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
0
-
Clostridium difficile (CDF) Nucleic Acid Test Cartridge
LUMINEX CORPORATION
The Verigene® Clostridium difficile Nucleic Acid Test (CDF) is a qualitative multiplexed in vitro diagnostic test for the rapid detection of toxin A (tcdA), toxin B (tcdB), and tcdC gene sequences of toxigenic Clostridium difficile and for presumptive identification of PCR ribotype 027 strains from unformed (liquid or soft) stool specimens collected from patients suspected of having C. difficile infection (CDI).
0
-
ARIES® C. difficile Assay
LUMINEX CORPORATION
The ARIES® C. difficile Assay is a real-time polymerase chain reaction (PCR) based qualitative in vitro diagnostic test for the direct detection of Clostridium difficile (C. difficile) nucleic acid in unformed (liquid or soft) stool specimens obtained from patients suspected of having Clostridium difficile infection (CDI).
0
-
Revogene® C. difficile
Meridian Bioscience Canada Inc
The Revogene® C. difficile assay performed on the Revogene instrument is a qualitative in vitro diagnostic test that utilizes automated sample processing and real-time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile (C. difficile) in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection (CDI). The Revogene C. difficile assay is intended to aid in the diagnosis of CDI.
0
-
GenePOC™ CDiff
GenePoc Inc
The GenePOC™ CDiff assay performed on the revogene™ instrument is a qualitative in vitro diagnostic test that utilizes automated sample processing and real-time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile (C. difficile) in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection (CDI). The GenePOC CDiff assay is intended to aid in the diagnosis of CDI.